Concerta for adults: label, side effects and generics

Concerta is a once-daily extended-release form of methylphenidate, one of the two main stimulant families used for ADHD. It is one of the few ADHD medications whose FDA label includes adult clinical trials and an explicit adult age range. This page summarizes the current Concerta label (effective April 20, 2026, checked on DailyMed October 19, 2026), its generics and the rules that apply in New York and New Jersey. It gives no doses and is not advice to start, stop or switch a medication.

What Concerta is

Concerta contains methylphenidate hydrochloride, a central nervous system (CNS) stimulant. The label says the way it works in ADHD "is not known," and adds that methylphenidate blocks the reuptake of norepinephrine and dopamine and increases their release. It is a Schedule II controlled substance. The basics of both stimulant families are in how ADHD medications work.

Is Concerta approved for adults?

Yes, with an age limit. The indication reads: ADHD "in patients aged 6 to 65 years old." The geriatric section adds that Concerta "is not indicated for use in patients greater than 65 years of age." For an adult over 65, use would be off-label, which is worth discussing with the prescriber. The label's adult dosing section is written for adults "up to 65 years of age."

The adult approval rests on two placebo-controlled trials in 627 adults aged 18 to 65 described in the label: a 7-week trial in which the dose was adjusted and a 5-week fixed-dose trial. In both, Concerta improved ADHD rating scale scores significantly more than placebo.

How the tablet works

• Once a day, in the morning, with or without food.
• Swallowed whole with liquid. The label says not to split, crush or chew it, because that would compromise the extended release and could affect safety or effectiveness.
• A shell may pass in the stool. The tablet does not change shape in the gut, and the label tells patients not to be concerned if they occasionally notice something that looks like a tablet in their stool.
• Long-acting. Average peak blood levels came 6 to 10 hours after a dose, and in the label's pediatric classroom studies, improvements were maintained through 12 hours.

The label compares this with immediate-release methylphenidate taken three times a day and says once-daily Concerta reduces the swings between peaks and troughs. The different release designs are explained in extended-release ADHD medications explained.

A caution for people with bowel narrowing

Because the tablet is nondeformable, the label says Concerta should not ordinarily be given to people with severe narrowing of the gastrointestinal tract, whether from disease or past surgery. Rare blockages have been reported in people with known strictures. Mention any history of bowel obstruction, strictures or major abdominal surgery.

Common side effects in adults

In the adult double-blind trials, the most common adverse reactions (5% or more) were decreased appetite, headache, dry mouth, nausea, insomnia, anxiety, dizziness, weight loss, irritability, fast heart rate (tachycardia) and excessive sweating. The reactions most often leading people to stop in the pediatric and adult trials were anxiety, irritability, insomnia and increased blood pressure. See ADHD medication side effects in adults for when to call the prescriber.

Boxed warning and other warnings

Like every prescription stimulant, Concerta carries a boxed warning on abuse, misuse and addiction: a high potential for misuse that can lead to a substance use disorder, and a risk of overdose and death with misuse. The FDA updated this warning for the whole class on May 11, 2023. Other label warnings cover serious heart disease, increases in blood pressure and heart rate, psychiatric effects (including new psychosis or mania), priapism, Raynaud's phenomenon, glaucoma and raised eye pressure, and tics. For heart questions, see ADHD medication, heart health and blood pressure.

Who should not take it

The contraindications are an allergy to methylphenidate or another ingredient, and use of a monoamine oxidase inhibitor (MAOI) now or within the previous 14 days because of the risk of hypertensive crisis.

Interactions

The label's interaction table names MAOIs, blood pressure medicines (whose effect Concerta may reduce), halogenated anesthetics on the day of surgery, and risperidone (a higher risk of movement side effects when either dose changes). ADHD medication drug interactions collects these across products.

Pregnancy and breastfeeding

Concerta's pregnancy section points to the National Pregnancy Registry for ADHD Medications. Its lactation section says limited published data show methylphenidate is present in human milk, no adverse effects on breastfed infants have been reported, and long-term effects on infant development are unknown. It advises monitoring the infant for reactions such as agitation, poor sleep, poor feeding and reduced weight gain. LactMed, the National Library of Medicine database, has a fuller summary.

Generic Concerta and a similar product

Several companies sell generic methylphenidate extended-release tablets whose labels copy Concerta's indication word for word, "patients aged 6 to 65 years old." Generic Concerta has a history worth knowing. In November 2014, the FDA said it had concerns about whether two generic versions, made by Mallinckrodt and Kudco, were therapeutically equivalent to the brand, and it changed their rating from AB to BX, meaning they were no longer recommended as automatically substitutable. In 2016 the FDA proposed withdrawing their approval. The FDA said the authorized generic was not affected. If you notice a difference after a pharmacy switch, tell your prescriber and pharmacist. The full story is in brand vs generic Concerta.

Relexxii is a separate brand of osmotic methylphenidate extended-release tablets. Its label covers ADHD in "adults (up to the age of 65 years) and pediatric patients 6 years of age and older," and it lists the same most common adult side effects as Concerta.

Supply in October 2026

As of mid-October 2026, FDA's drug shortage database listed methylphenidate extended-release among current shortages. Strength-by-strength availability changes, so ask the pharmacy before a prescription runs out. ADHD medication shortages in New York lists lawful options such as partial fills and transfers.

New York and New Jersey prescription rules

Concerta is Schedule II, so no refills are allowed in either state. New York limits a prescription to a 30-day supply unless it is written for a condition the state allows up to three months for, which includes attention deficit disorder; see New York's rules for ADHD stimulant prescriptions. New Jersey limits each prescription to 30 days, with multiple dated prescriptions allowed up to 90 days, and since July 8, 2026 requires an in-person visit within 30 days for adults located in New Jersey who start a Schedule II stimulant by telehealth; see New Jersey's ADHD medication rules.

How Concerta compares

A 2018 network meta-analysis in Lancet Psychiatry found methylphenidate reduced adult ADHD symptoms more than placebo at about 12 weeks. NICE in the UK recommends lisdexamfetamine or methylphenidate as first-line options for adults. Side-by-side pages: Concerta vs Ritalin and Vyvanse vs Concerta.

Questions to ask your prescriber

• Is a once-daily tablet a good fit for my schedule, and what if I need coverage late in the evening?
• Will the pharmacy dispense brand or generic, and which manufacturer?
• I have had abdominal surgery or bowel problems. Does that matter for this tablet?
• How will my blood pressure and pulse be followed?
• I am over 65, or will be soon. What does the label's age limit mean for me?

Dr. Shershow provides adult ADHD evaluation and, when medication is appropriate, medication management with follow-up visits. See adult ADHD treatment.